[Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports]
- PMID: 8659335
[Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports]
Abstract
Administration of intravesical chemotherapy by mitomycin C (MMC) is an adjuvant treatment of the recurrent superficial bladder cancer. Since use of MMC in 1967, many different toxicities were reported. Those are local toxicities. Systemic toxicity is rare. At the hand of 2 cases reports and recent literature, we discuss the possible complications of intravesical therapy with MMC.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical